About Manfred Pharmaceuticals
Manfred Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing and marketing of medicinal products in India. Its Indian entity Manfred Pharmaceuticals Private Limited reported revenue of ₹11.5 Lakh. Manfred Pharmaceuticals offers products and services including Syrup and Tablets. Its focus areas include Healthcare Services, Product Distribution, Pharmaceutical Distribution and Pharmaceuticals.
Company details
Manfred Pharmaceuticals Pvt. Ltd. was incorporated in 2011 with a vision to develop and market innovative pharmaceutical products aimed at preventing and curing diseases while easing suffering and enhancing quality of life. It is recognized as an active company in India, offering items such as syrups, tablets, and capsules. The company is committed to providing affordable medicines that meet global standards and seeks to achieve market leadership domestically. Operations began as a marketing-focused entity, with products launched to spread the brand across India, emphasizing accessibility and quality in healthcare solutions.
- SectorsHealthcare
- Email••••••••
- Legal Name Manfred Pharmaceuticals Pvt. Ltd
- Date of Incorporation 12 Sep, 2011
- Jurisdiction Kolhapur, Maharashtra, India
- Indian entity revenue₹11.5 Lakh
FY 2025 · +24% YoY
- Indian entity net loss-₹79,637
FY 2025 · -7% margin
- Indian entity EBITDA-₹78,182
FY 2025 · -7% margin
Associated legal entities of Manfred Pharmaceuticals
Manfred Pharmaceuticals operates through Manfred Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Manfred Pharmaceuticals Private Limited CIN U24233PN2011PTC140740 | Active | 12 Sep 2011 | Kolhapur, Maharashtra | ₹0.1 Cr | 2 | View details |
Products & Services of Manfred Pharmaceuticals
Manfred Pharmaceuticals offers a comprehensive portfolio of products and services, including Syrup and Tablets.
Syrups are prepared as concentrated solutions of sugar in water or other aqueous mixtures where the medicinal substance is dissolved for therapeutic purposes.
Tablets are manufactured in various sizes ranging from 1 mm to 22 mm as solid pharmaceutical dosage forms to support end-user needs.
Board of directors of Manfred Pharmaceuticals Private Limited (Manfred Pharmaceuticals)
Manfred Pharmaceuticals Private Limited is the primary company behind Manfred Pharmaceuticals. The board of Manfred Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Yogesh Balavant Ghewade, appointed in 2011. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Yogesh Balavant Ghewade DIN 03538320 | Director | 12 Sep 2011 | 15 yrs 1 mo | Manfred Pharmaceuticals Private Limited |
| Smita Yogesh Ghewade DIN 09526390 | Director | 05 Mar 2022 | 4 yrs 7 mo | Manfred Pharmaceuticals Private Limited |
Financials of Manfred Pharmaceuticals
Figures of Manfred Pharmaceuticals Private Limited, the primary company behind Manfred Pharmaceuticals, for FY 2025. Revenue was ₹11.5 Lakh (+24% year on year). Net loss was -₹79,637 (-7% margin). EBITDA was -₹78,182 (-7% margin). Revenue has grown at a compounded annual rate of +18% over three years and +15% over five years.
- ₹11.5 LakhRevenue · FY 2025 · +24% YoY
- -₹79,637Net loss · -7% margin
- -₹78,182EBITDA · -7% margin
- ₹1 LakhPaid-up capital
- +18%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Manfred Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Manfred Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Manfred Pharmaceuticals
The primary company behind Manfred Pharmaceuticals, Manfred Pharmaceuticals Private Limited, reported revenue of ₹11.5 Lakh for FY 2025, up 24% year on year.
Manfred Pharmaceuticals Pvt. Ltd. was incorporated in 2011 with a vision to develop and market innovative pharmaceutical products aimed at preventing and curing diseases while easing suffering and enhancing quality of life. It is recognized as an active company in India, offering items such as syrups, tablets, and capsules. The company is committed to providing affordable medicines that meet global standards and seeks to achieve market leadership domestically. Operations began as a marketing-focused entity, with products launched to spread the brand across India, emphasizing accessibility and quality in healthcare solutions.
Manfred Pharmaceuticals offers Syrup and Tablets.
Manfred Pharmaceuticals operates through Manfred Pharmaceuticals Private Limited.
The legal entities of Manfred Pharmaceuticals currently have 2 directors, including Smita Yogesh Ghewade, Yogesh Balavant Ghewade.